Detailed information of each patient examined in the study
| Patient | Sex/age (y) | Diagnosis | Joint | Patient | Sex/age (y) | Diagnosis | Duration (y) | Joint | Activity | Stage* |
|---|---|---|---|---|---|---|---|---|---|---|
| N- 1 | F/70 | FNF | Hip | R-1 | F/56 | RA | 15 | Knee | Active | III |
| 2 | F/64 | FNF | Hip | 2 | F/37 | RA | 14 | Knee | Active | III |
| 3 | F/74 | FNF | Hip | 3 | F/51 | RA | 8 | Knee | Active | III |
| 4 | F/85 | FNF | Hip | 4 | F/59 | RA | 10 | Knee | Active | III |
| 5 | M/18 | CS | Knee | 5 | F/67 | RA | 20 | Knee | Active | III |
| 6 | F/18 | FS | Ankle | 6 | F/58 | RA | 11 | Knee | Active | III |
| O- 1 | F/57 | OA | Hip | 7 | F/72 | RA | 23 | Knee | Active | III |
| 2 | F/73 | OA | Hip | 8 | F/36 | RA | 4 | Knee | Active | III |
| 3 | F/63 | OA | Knee | 9 | F/53 | RA | 21 | Knee | Active | III |
| 4 | F/77 | OA | Knee | 10 | F/76 | RA | 21 | Knee | Active | III |
| 5 | F/72 | OA | Knee | 11 | F/50 | RA | 12 | Knee | Inactive | III |
| 6 | F/67 | OA | Knee | 12 | F/61 | RA | 20 | Knee | Inactive | III |
| 7 | F/75 | OA | Knee | 13 | F/41 | RA | 9 | Knee | Inactive | III |
| 8 | F/64 | OA | Knee | 14 | F/52 | RA | 9 | Knee | Inactive | III |
| 9 | F/75 | OA | Knee | 15 | M/65 | RA | 14 | Knee | Inactive | III |
| 10 | F/67 | OA | Knee |
N- 1–6: normal cartilage, O- 1–10: OA cartilage, R- 1–15: RA cartilage. FNF: femoral neck fracture, CS: chondrosarcoma, FS: fibrosarcoma, OA: osteoarthritis, RA: rheumatoid arthritis. Active: serum CRP >1.0 mg/dl, *Steinbrocker’s classification.46